APA (7th ed.) Citation

Wong, G. L., Gane, E., Pan, C. Q., Fung, S., Ma, M. M., Izumi, N., . . . Buti, M. (2025, August 12). Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.70327

Chicago Style (17th ed.) Citation

Wong, Grace Lai‐Hung, et al. "Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment." Alimentary Pharmacology & Therapeutics 12 Aug. 2025. https://doi.org/10.1111/apt.70327.

MLA (9th ed.) Citation

Wong, Grace Lai‐Hung, et al. "Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment." Alimentary Pharmacology & Therapeutics, 12 Aug. 2025, https://doi.org/10.1111/apt.70327.